Month: January 2018

Compounding pharmacy increasingly popular during flu season

  Compounding pharmacy has become increasingly popular across Central Florida since the uptick in flu cases. Eyewitness News reported last week that there is a shortage of the generic version of Tamiflu and the price of brand-name of Tamiflu has skyrocketed. Compound pharmacies, which are different from retail pharmacies, have the ability to make a …

Compounding pharmacy increasingly popular during flu season Read More »

FDA Releases Compounding Priorities Plan

The U.S. Food and Drug Administration on Jan. 24 issued its 2018 Compounding Policy Priorities Plan, which outlines how the agency will implement key aspects of the Drug Quality and Security Act and other provisions of the law relevant to compounders. That law was enacted after a fungal meningitis outbreak in 2012 stemming from the New England …

FDA Releases Compounding Priorities Plan Read More »

Top Organizations Urge a Concerted Effort To Improve Safety in Hospital Compounding

Five years after the New England Compounding Center (NECC) tragedy that brought to light safety problems stemming from the compounding of pharmaceuticals and other therapies, a white paper was released today reflecting the recommendations of major stakeholders for additional steps needed to improve patient safety relative to compounded medicines.  The paper was the outcropping of a milestone …

Top Organizations Urge a Concerted Effort To Improve Safety in Hospital Compounding Read More »

Hospitals face shortage of IV bags amid flu outbreak

   TREASURE VALLEY — Hospitals across the nation continue to battle a shortage of IV solution bags – now, amid an early and aggressive flu season. Hospitals are having to get creative, including those here at home. Area hospitals – like many across the country – have been wrestling with this shortage for months. But …

Hospitals face shortage of IV bags amid flu outbreak Read More »

FDA Unveils Guidance To Smooth Generic-Drug Path

Law360, New York (January 3, 2018, 5:48 PM EST) — The U.S. Food and Drug Administration on Wednesday unveiled draft guidance for the pharmaceutical industry and an internal manual of policies and procedures that it says will streamline the approval process for generic drugs, in part by reducing the number of times an application must be reviewed. …

FDA Unveils Guidance To Smooth Generic-Drug Path Read More »